The COVID-19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics

Clin Transl Sci. 2021 May;14(3):777-780. doi: 10.1111/cts.12954. Epub 2021 Jan 21.

Uttara Soumyanarayanan¹, Mimi Choong², James Leong¹, Murray M Lumpkin³, Guido Rasi⁴, John H Skerritt⁵, Silke Vogel¹, John C W Lim^{1

6

7}

¹ Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School, Singapore City, Singapore.
² Health Sciences Authority (HSA), Singapore City, Singapore.
³ The Bill & Melinda Gates Foundation, Seattle, Washington, USA.
⁴ University Tor Vergata, Rome, Italy.
⁵ Department of Health, Canberra, New South Wales, Australia.
⁶ SingHealth Duke-NUS Global Health Institute (SDGHI), Singapore City, Singapore.
⁷ Consortium for Clinical Research & Innovation Singapore (CRIS), Singapore City, Singapore.

No abstract available

MeSH terms